Insider Trading & Ownership - Rolke James

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Rolke James

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-02-25
Option Award
2023-02-28
4:08 pm
N/A
2032-02-25
REVELATION BIOSCIENCES INC.REVBRolke James
Chief Executive Officer
2,542$00
(Direct)
View

Ownership
2022-01-20
6:03 pm
N/A
N/A
REVELATION BIOSCIENCES INC.REVBRolke James
Chief Executive Officer
0$0757,064
(Direct)
View
2020-05-29
Option Award
2020-06-02
4:02 pm
N/A
2030-05-29
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
205$081,976
(Direct)
View
2020-05-29
Option Award
2020-06-02
4:02 pm
N/A
N/A
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
205$4.0181,976
(Direct)
View
2020-05-15
Option Award
2020-05-19
4:05 pm
N/A
2030-05-15
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
140$081,706
(Direct)
View
2020-05-15
Option Award
2020-05-19
4:05 pm
N/A
N/A
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
140$5.8681,706
(Direct)
View
2020-04-30
Option Award
2020-05-04
4:09 pm
N/A
2030-04-30
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
133$081,559
(Direct)
View
2020-04-30
Option Award
2020-05-04
4:09 pm
N/A
N/A
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
133$6.1781,559
(Direct)
View
2020-04-15
Option Award
2020-04-17
4:02 pm
N/A
2030-04-15
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
146$081,439
(Direct)
View
2020-04-15
Option Award
2020-04-17
4:02 pm
N/A
N/A
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
146$5.6181,439
(Direct)
View
2020-03-31
Option Award
2020-04-02
6:08 pm
N/A
N/A
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
229$3.5781,376
(Direct)
View
2020-03-31
Option Award
2020-04-02
6:08 pm
N/A
2030-03-31
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
229$081,376
(Direct)
View
2020-03-13
Option Award
2020-03-16
4:13 pm
N/A
2030-03-13
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
241$081,159
(Direct)
View
2020-03-13
Option Award
2020-03-16
4:13 pm
N/A
N/A
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
241$3.481,159
(Direct)
View
2020-02-28
Option Award
2020-03-03
4:14 pm
N/A
2030-02-28
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
142$080,819
(Direct)
View
2020-02-28
Option Award
2020-03-03
4:14 pm
N/A
N/A
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
142$5.7880,819
(Direct)
View
2020-02-14
Option Award
2020-02-19
4:47 pm
N/A
2030-02-14
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
115$080,650
(Direct)
View
2020-02-14
Option Award
2020-02-19
4:47 pm
N/A
N/A
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
115$7.1480,650
(Direct)
View
2020-01-31
Option Award
2020-02-04
4:01 pm
N/A
2030-01-31
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
141$080,561
(Direct)
View
2020-01-31
Option Award
2020-02-04
4:01 pm
N/A
N/A
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
141$5.8280,561
(Direct)
View
2020-01-15
Option Award
2020-01-17
4:13 pm
N/A
2030-01-15
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
692$080,971
(Direct)
View
2020-01-15
Option Award
2020-01-17
4:13 pm
N/A
N/A
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
692$6.780,971
(Direct)
View
2020-01-09
Option Award
2020-01-13
4:19 pm
N/A
2030-01-09
LA JOLLA PHARMACEUTICAL COLJPCRolke James
Chief Scientific Officer
30,000$030,000
(Direct)
View